Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Abdominal Neoplasms × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Pain 3 Pain, Postoperative 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Postoperative Complications 1 Ovarian Cysts 1 Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Advanced Ovarian Cancer 1 Abdominal Neoplasms 1

Interventions

Ropivacaine 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06430112 2024-05-28

Liposomal Bupivacaine vs Ropivacaine for TAPBs

Sun Yat-sen University

Phase 3 Recruiting

Abdominal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡